{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:30:39Z","timestamp":1791243039853,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021817","name":"Knud og Edith Eriksens Mindefond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Biologic disease-modifying drugs have revolutionised the treatment of a number of chronic inflammatory diseases (CID). However, up to 60% of the patients do not have a sufficient response to treatment and there is a need for optimization of treatment strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate if the treatment outcome of biological therapy is associated with the habitual dietary intake of fibre and red\/processed meat in patients with a CID.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this multicentre prospective cohort study, we consecutively enrolled 233 adult patients with a diagnosis of Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis (RA), Axial Spondyloarthritis, Psoriatic Arthritis and Psoriasis, for whom biologic therapy was planned, over a 3 year period. Patients with completed baseline food frequency questionnaires were stratified into a high fibre\/low red and processed meat exposed group (HFLM) and an unexposed group (low fibre\/high red and processed meat intake = LFHM). The primary outcome was the proportion of patients with a clinical response to biologic therapy after 14\u201316 weeks of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 193 patients included in our primary analysis, 114 (59%) had a clinical response to biologic therapy. In the HFLM group (<jats:italic>N<\/jats:italic> = 64), 41 (64%) patients responded to treatment compared to 73 (56%) in the LFHM group (<jats:italic>N<\/jats:italic> = 129), but the difference was not statistically significant (OR: 1.48, 0.72\u20133.05). For RA patients however, HFLM diet was associated with a more likely clinical response (82% vs. 35%; OR: 9.84, 1.35\u201371.56).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Habitual HFLM intake did not affect the clinical response to biological treatment across CIDs. HFLM diet in RA patients might be associated with better odds for responding to biological treatment, but this would need confirmation in a randomised trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>(<jats:ext-link>clinicaltrials.gov<\/jats:ext-link>), identifier [NCT03173144].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2022.985732","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T12:17:23Z","timestamp":1665663443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of fibre and red\/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study"],"prefix":"10.3389","volume":"9","author":[{"given":"Silja H.","family":"Overgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe B.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi L.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders B.","family":"Nex\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Glerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke H.","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Guldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Saboori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Hvid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens F.","family":"Dahlerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Jawhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina W.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Bergenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob B.","family":"Brodersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit L.","family":"Heitmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorhallur I.","family":"Halldorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe","family":"Holmskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Bygum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torkell","family":"Ellingsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","article-title":"Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics","volume":"8","author":"Li","year":"2017","journal-title":"Front Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses\u2014part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41575-019-0228-5","article-title":"Interrogating host immunity to predict treatment response in inflammatory bowel disease","volume":"17","author":"Digby-Bell","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1056\/NEJMct1209614","article-title":"Tumour necrosis factor inhibitors for inflammatory bowel disease","volume":"369","author":"Nielsen","year":"2013","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","article-title":"The gut-joint axis in rheumatoid arthritis","volume":"17","author":"Zaiss","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41575-019-0248-1","article-title":"Host-microbiota interactions in inflammatory bowel disease","volume":"17","author":"Neurath","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/pathogens9060463","article-title":"Gut microbiome in psoriasis: an updated review","volume":"9","author":"Sikora","year":"2020","journal-title":"Pathogens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3390\/ijms21155405","article-title":"Nutrition and psoriasis","volume":"21","author":"Kanda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"158900","DOI":"10.1016\/j.bbalip.2021.158900","article-title":"Effects of short chain fatty acids on metabolic and inflammatory processes in human health","volume":"1866","author":"Campos-Perez","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"B19","doi-asserted-by":"publisher","first-page":"104947","DOI":"10.1016\/j.phrs.2020.104947","article-title":"Microbiota-derived butyrate regulates intestinal inflammation: focus on inflammatory bowel disease","volume":"159","author":"Couto","year":"2020","journal-title":"Pharmacol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fibre-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/apt.13456","article-title":"Review article: insights into colonic protein fermentation, its modulation and potential health implications","volume":"43","author":"Yao","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e018166","DOI":"10.1136\/bmjopen-2017-018166","article-title":"Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine","volume":"8","author":"Christensen","year":"2018","journal-title":"BMJ Open."},{"key":"B23","doi-asserted-by":"publisher","first-page":"W163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"B25","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"B26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1403494810393557","article-title":"The Danish health examination survey 2007\u20132008 (DANHES 2007\u20132008)","volume":"39","author":"Eriksen","year":"2011","journal-title":"Scand J Public Health."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1017\/S1368980014002389","article-title":"Missing portion sizes in FFQ\u2014alternatives to use of standard portions","volume":"18","author":"K\u00f8ster-Rasmussen","year":"2015","journal-title":"Public Health Nutr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American college of rheumatology. Preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum."},{"key":"B29","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The assessment of spondyloarthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med."},{"key":"B31","volume-title":"Multiple Imputation of Missing Data Using SAS","author":"Berglund","year":"2014"},{"key":"B32","first-page":"253","volume-title":"Multiple Imputation for Nonresponse in Surveys. Wiley Series in Probability and Mathematical Statistics. Applied Probability and Statistics","author":"Rubin","year":"1987"},{"key":"B33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2014.9440","article-title":"Multiple comparison procedures","volume":"312","author":"Cao","year":"2014","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ."},{"key":"B35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jclinepi.2021.03.009","article-title":"Effect modifiers and statistical tests for interaction in randomised trials","volume":"134","author":"Christensen","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/1756283X15578607","article-title":"Specialised enteral nutrition therapy in Crohn's disease patients on maintenance infliximab therapy: a meta-analysis","volume":"8","author":"Nguyen","year":"2015","journal-title":"Therap Adv Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7812\/TPP\/14-124","article-title":"High amount of dietary fibre not harmful but favourable for Crohn's disease","volume":"19","author":"Chiba","year":"2015","journal-title":"Perm J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/nu13020699","article-title":"Nutritional components in western diet vs. mediterranean diet at the gut microbiota-immune system interplay. Implications for health and disease","volume":"13","author":"Garc\u00eda-Montero","year":"2021","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","first-page":"a1344","DOI":"10.1136\/bmj.a1344","article-title":"Adherence to mediterranean diet and health status: meta-analysis","volume":"337","author":"Sofi","year":"2008","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fmed.2018.00349","article-title":"Diet, microbiota, and gut permeability-the unknown triad in rheumatoid arthritis","volume":"5","author":"Guerreiro","year":"2018","journal-title":"Front Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1017\/S095442241700004X","article-title":"Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health","volume":"30","author":"Stephen","year":"2017","journal-title":"Nutr Res Rev."},{"key":"B42","unstructured":"PedersenAN\n            ChristensenT\n            MatthiessenJ\n            KnudsenVK\n            Rosenlund-S\u00f8rensenM\n            Biltoft-JensenA\n          DTU National Food InstituteDanskernes kostvaner 2011\u201320132015"},{"key":"B43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(18)31788-4","article-title":"Food in the anthropocene: the EAT-lancet commission on healthy diets from sustainable food systems","volume":"393","author":"Willett","year":"2019","journal-title":"Lancet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S0954422419000295","article-title":"The role of meat in the European diet: current state of knowledge on dietary recommendations, intakes and contribution to energy and nutrient intakes and status","volume":"33","author":"Cocking","year":"2020","journal-title":"Nutr Res Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Sarkar","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.autrev.2018.06.001","article-title":"Mechanistic immunological based classification of rheumatoid arthritis","volume":"17","author":"McGonagle","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e000880","DOI":"10.1136\/rmdopen-2018-000880","article-title":"Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based corrona registry","volume":"5","author":"Mease","year":"2019","journal-title":"RMD Open."},{"key":"B50","doi-asserted-by":"publisher","first-page":"Pi17","DOI":"10.12659\/MSM.883250","article-title":"Do patients with active RA have differences in disease activity and perceptions if anti-TNF naive vs. anti-TNF experienced? Baseline results of the optimization of adalimumab trial","volume":"18","author":"Pope","year":"2012","journal-title":"Med Sci Monit."},{"key":"B51","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar1881","article-title":"Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a 4-year period","volume":"8","author":"Gomez-Reino","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/ecco-jcc\/jjab116","article-title":"Nutrient, fibre, and FODMAP intakes and food-related quality of life in patients with inflammatory bowel disease, and their relationship with gastrointestinal symptoms of differing aetiologies","volume":"15","author":"Cox","year":"2021","journal-title":"J Crohns Colitis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.20524\/aog.2018.0273","article-title":"Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population","volume":"31","author":"Principi","year":"2018","journal-title":"Ann Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","article-title":"Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome","volume":"70","author":"Bolte","year":"2021","journal-title":"Gut."}],"updated-by":[{"DOI":"10.3389\/fnut.2022.1091846","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000}}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.985732\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T12:51:41Z","timestamp":1670417501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.985732\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":55,"alternative-id":["10.3389\/fnut.2022.985732"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.985732","relation":{"erratum":[{"id-type":"doi","id":"10.3389\/fnut.2022.1091846","asserted-by":"object"}]},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"article-number":"985732"}}